Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Skin DC PLLC

Neither a doctor nor a teaching hospital

Research payments

$1,948,598

166 payments

Through program year 2025, Skin DC PLLC is reported as receiving $1,948,598 in research payments, across 166 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $636,446 47
2024 Research $292,797 25
2023 Research $532,676 9
2022 Research $35,843 4
2021 Research $84,487 20
2020 Research $186,395 40
2019 Research $179,953 21

Breakdown

Who paid Research payments · program years 2019–2025
  1. AbbVie, Inc. $1,497,763 85 payments
  2. Allergan Inc. $450,836 81 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naive Adult Participants With Glabellar Lines $519,521 5 payments
  2. BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study $244,166 13 payments
  3. A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL) $213,224 9 payments
  4. A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $95,451 11 payments
  5. Ph 3 Pivotal GL and GLLCL - USEU $91,736 7 payments
  6. A Prospective Multi-center Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administration of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Upper Facial Lines (Glabellar Lines Lateral Canthal Lines and Forehead Lines) $90,611 13 payments
  7. M21-416 - BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study $84,550 4 payments
  8. Ph 3 Pivotal GL and GL+LCL - US/EU $74,813 8 payments
  9. A multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of Juvederm VOLUMA XC injectable gel for restoring jawline definition $66,119 18 payments
  10. A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System $65,945 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record